The study concluded that EGFR mutational pattern heterogeneity frequency is relatively low, more commonly observed in multiple lung tumors, and that 38,2% of heterogenous pattern patients showed a variable tumor response to EGFR TKIs, with frequent development of EGFR resistance [31]. This evidence concerns the gene EGFR and neoplasm.